House Panel: Defund Studies on Fetal Tissue Obtained from Abortions

The US House of Representatives “Select Investigative Panel” recommends that the NIH investigate fetal tissue research, and consider no longer funding certain types.

Written byJoshua A. Krisch
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, DILIFFHouse Republicans on a special panel have renewed calls to defund the health care organization Planned Parenthood, and are now recommending that the National Institutes of Health (NIH) cut funding for some forms of fetal tissue research, Nature reported last week (January 3).

The panel—established in 2015 after videos surfaced of Planned Parenthood officials discussing how fetal tissue is gathered and purchased—recommended that the NIH commission studies to determine whether fetal tissue obtained from stillborn and preterm infants alone could meet the needs of the scientific community and, if so, that the agency phase out funding for tissue obtained from induced abortions.

“Scientific societies and universities have made misleading claims about fetal tissue research,” according to the report. “The Select Panel has received letters from 21 institutions. . . . In reality, not a single responding institution provided substantive evidence for the value of fetal tissue research.”

But experts maintain that fetal tissue obtained from abortions is vital to scientific research. Scientists note that fetal tissue has helped ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies